Market revenue in 2023 | USD 989.0 million |
Market revenue in 2030 | USD 1,419.4 million |
Growth rate | 5.3% (CAGR from 2023 to 2030) |
Largest segment | Frozen nondonor |
Fastest growing segment | Fresh Donor |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor |
Key market players worldwide | Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro fertilization market will help companies and investors design strategic landscapes.
Frozen nondonor was the largest segment with a revenue share of 48.38% in 2023. Horizon Databook has segmented the Spain in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2018 to 2030.
The success rates for regular ART cycles in Spain ranged from 8% to 27%, with the rate varying based on the age of the patient. Younger patients typically had higher success rates compared to older patients. It is important to note that success rates can also be influenced by factors such as the cause of infertility, the quality of embryos, and the specific protocols used.
Furthermore, for cycles using donor eggs, the success rates were generally higher in Spain. The average success rate for donor-egg cycles in Spain was around 37%. This higher success rate can be attributed to the use of young and healthy donor eggs, which can improve the chances of a successful pregnancy.
According to a study published in March 2021 by Health Europe, between 2011 and 2021, there has been a significant decline in the number of annual births in Spain, with a decrease of 29%. This decline in the birth rate has raised concerns about the country's population dynamics and future demographic trends.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain in vitro fertilization market , including forecasts for subscribers. This country databook contains high-level insights into Spain in vitro fertilization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account